NSN 6505-01-593-0020
Part Details | USP HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS
6505-01-593-0020
Alternate Parts: NDC52544016101, NDC52544-0161-01, NDC00591261201, NDC00591-2612-01, NORCO 10325MG TAB 100, NORCO 10/325MG TAB 100, 22788, 6505NCM116018, NDC00603388721, NDC00603-3887-21, NDC00406012501, NDC00406-0125-01, LORTAB 10325MG TAB 100, LORTAB 10/325MG TAB 100, NDC50474093201, NDC50474-0932-01, 6505-01-593-0020, 01-593-0020, 6505015930020, 015930020
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | MAR 31, 2011 | 01-593-0020 | 50980 ( HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-593-0020
Part Number | Cage Code | Manufacturer |
---|---|---|
NDC52544-0161-01 | 6LMB8 | ACTAVIS PHARMA, INC. |
NDC00591-2612-01 | 6LMB8 | ACTAVIS PHARMA, INC. |
NORCO 10/325MG TAB 100 | 6LMB8 | ACTAVIS PHARMA, INC. |
22788 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
6505NCM116018 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
NDC00603-3887-21 | 0ET99 | GENERICS BIDCO I, LLCDBA PAR PHARMACEUTICAL |
NDC00406-0125-01 | 1SJ92 | MALLINCKRODT LLCDIV DOSAGE PHARMACEUTICAL |
LORTAB 10/325MG TAB 100 | 6E8S1 | TRIS PHARMA INC. |
NDC50474-0932-01 | 0S423 | UCB PHARMA, INC. |
Technical Data | NSN 6505-01-593-0020
Characteristic | Specifications |
---|---|
ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB10.000 MILLIGRAMS HYDROCODONE BITARTRATE AND AB325.000 MILLIGRAMS ACETAMINOPHEN |
ADMINISTRATION | ORAL |
PRIMARY CONTAINER TYPE | BOTTLE |
PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
FEATURES PROVIDED | CHILD RESISTANT CLOSURE |
SPECIAL FEATURES | HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS, USP; EACH TABLET CONTAINS 10 MG HYDROCODONE BITARTRATE AND 325 MG ACETAMINOPHEN; STORE AT ROOM TEMPERATURE; PROTECT FROM LIGHT; BOTTLE OF 100 TABLETS |
PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
PART NAME ASSIGNED BY CONTROLLING AGENCY | HYDROCOD APAP 10/ 325MG TAB 100S |
CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE II |